Thu, March 25, 2021
Wed, March 24, 2021
Tue, March 23, 2021

Jason Gerberry Downgraded (BHC) to Sell and Held Target at $27 on, Mar 24th, 2021

Jason Gerberry of B of A Securities, Downgraded "Bausch Health Companies Inc." (BHC) to Sell and Held Target at $27 on, Mar 24th, 2021.

Jason has made no other calls on BHC in the last 4 months.



There are 4 other peers that have a rating on BHC. Out of the 4 peers that are also analyzing BHC, 1 agrees with Jason's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • David Risinger of "Morgan Stanley" Maintained at Hold with Increased Target to $35 on, Friday, February 26th, 2021


These are the ratings of the 3 analyists that currently disagree with Jason


  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $55 on, Tuesday, March 16th, 2021
  • Douglas Miehm of "RBC Capital" Upgraded from Hold to Buy and Increased Target to $42 on, Wednesday, February 17th, 2021
  • David Steinberg of "Jefferies" Maintained at Strong Buy with Increased Target to $33 on, Friday, January 15th, 2021